je.st
news
Novogen Announces Breakthrough Discovery In The Treatment Of Melanoma
2014-12-29 02:07:31| drugdiscoveryonline Home Page
Novogen Limited (ASX:NRT; NASDAQ: NVGN), Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma
Tags: treatment
discovery
announces
breakthrough
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||